Literature DB >> 22382600

Sex, susceptibility to smoking and chronic obstructive pulmonary disease: the effect of different diagnostic criteria. Analysis of the Health Survey for England.

Rachel E Jordan1, Martin R Miller, Kin-Bong Hubert Lam, K K Cheng, Jennifer Marsh, Peymané Adab.   

Abstract

BACKGROUND: Some previous studies suggest there are sex differences in susceptibility to, and prevalence of, chronic obstructive pulmonary disease (COPD) but findings are inconsistent. In this study, whether different diagnostic criteria for COPD may contribute to these conflicting findings was examined.
METHODS: Cross sectional analysis of data from the 1995, 1996 and 2001 Health Survey for England was undertaken, including participants of white ethnicity, aged 40+ years with a valid smoking history and lung function data. COPD was defined using Global Initiative for Chronic Obstructive Lung Disease (GOLD), National Institute for Health and Clinical Excellence (NICE) and lower limit of normal (LLN) spirometric criteria, in the absence of a diagnosis of asthma.
RESULTS: COPD was present in 3035 (16.1%), 1304 (7.0%) and 1684 (9.0%) people, according to the GOLD, NICE and LLN criteria, respectively. With both the GOLD and NICE definitions, men had significant independent increased risks of COPD compared with women (OR 1.46 (95% CI 1.34 to 1.59) and 1.30 (1.15 to 1.48), respectively). With the LLN definition, this effect was removed (OR 0.96 (0.87 to 1.07). With the use of both the GOLD and NICE criteria, women had significantly greater susceptibility to COPD (25-30% higher risk) for the same level of pack years of exposure. This was not observed with the LLN criteria.
CONCLUSIONS: The study indicates that sex differences in risk of COPD reported in previous studies are influenced by the definition used for COPD. When using a statistically driven definition (LLN), no independent sex difference was found and there was no evidence of an increased susceptibility to COPD among female compared with male smokers.

Entities:  

Mesh:

Year:  2012        PMID: 22382600     DOI: 10.1136/thoraxjnl-2011-201384

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

Review 1.  Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.

Authors:  Hannu Kankaanranta; Terttu Harju; Maritta Kilpeläinen; Witold Mazur; Juho T Lehto; Milla Katajisto; Timo Peisa; Tuula Meinander; Lauri Lehtimäki
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-01-22       Impact factor: 4.080

2.  Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique.

Authors:  Ignacio Blanco; Isidro Diego; Patricia Bueno; Eloy Fernández; Francisco Casas-Maldonado; Cristina Esquinas; Joan B Soriano; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-21

3.  Spirometry is not enough to diagnose COPD in epidemiological studies: a follow-up study.

Authors:  Elena Andreeva; Marina Pokhaznikova; Anatoly Lebedev; Irina Moiseeva; Olga Kuznetsova; Jean-Marie Degryse
Journal:  NPJ Prim Care Respir Med       Date:  2017-11-14       Impact factor: 2.871

4.  Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history.

Authors:  Yong Liu; Roy A Pleasants; Janet B Croft; Anne G Wheaton; Khosrow Heidari; Ann M Malarcher; Jill A Ohar; Monica Kraft; David M Mannino; Charlie Strange
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-21

Review 5.  Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.

Authors:  Davies Adeloye; Stephen Chua; Chinwei Lee; Catriona Basquill; Angeliki Papana; Evropi Theodoratou; Harish Nair; Danijela Gasevic; Devi Sridhar; Harry Campbell; Kit Yee Chan; Aziz Sheikh; Igor Rudan
Journal:  J Glob Health       Date:  2015-12       Impact factor: 7.664

6.  Estimating population prevalence of potential airflow obstruction using different spirometric criteria: a pooled cross-sectional analysis of persons aged 40-95 years in England and Wales.

Authors:  Shaun Scholes; Alison Moody; Jennifer S Mindell
Journal:  BMJ Open       Date:  2014-07-23       Impact factor: 2.692

7.  Insights into the aetiology of snoring from observational and genetic investigations in the UK Biobank.

Authors:  Adrián I Campos; Luis M García-Marín; Enda M Byrne; Nicholas G Martin; Gabriel Cuéllar-Partida; Miguel E Rentería
Journal:  Nat Commun       Date:  2020-02-14       Impact factor: 14.919

Review 8.  Women's COPD.

Authors:  Maéva Zysman; Chantal Raherison-Semjen
Journal:  Front Med (Lausanne)       Date:  2022-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.